Publications

Vivli AMR Register

Publications

 

Researchers have used data from the Vivli AMR Register in 36 publications, including peer-reviewed articles, preprints, and theses. Each title links to the full publication.

36

publications since 2023

31

from AMR Data Challenge research

15

published in 2026

Publications by year

All publications

Showing 36 of 36 publications

2026 15 publications

  1. A comprehensive AMR genotype–phenotype database (CABBAGE)
    Nucleic Acids ResearchData Challenge
    Data from: Pfizer
  2. Advancing monitoring of antimicrobial resistance trajectories using flexible spatiotemporal modelling: a change-point analysis
    Wellcome Open ResearchData Challenge
    Data from: Pfizer
  3. AMROrbit: a trajectory-based scorecard for antimicrobial stewardship using routine susceptibility testing data
    JAC-Antimicrobial ResistanceData Challenge
    Data from: Pfizer
  4. Childhood Antimicrobial Resistance With Global Forecasts
    JAMA PediatricsData Challenge
    Data from: Pfizer
  5. Country-Level Variation in Acinetobacter baumannii Resistance across North America, Central America, and the Caribbean: A Phenotypic and Plasmid Genomic Analysis of ATLAS Surveillance Data, 2000–2021
    Wellcome Open ResearchData Challenge
    Data from: Pfizer
  6. Distribution of extended spectrum beta-lactamase antibiotic resistance in Africa 2005-2021
    Wellcome Open ResearchData Challenge
    Data from: Pfizer
  7. Exploring the evolution of multidrug resistance patterns in ESKAPEE pathogens using association mining: Key to antibiotic stewardship?
    Wellcome Open ResearchData Challenge
    Data from: Pfizer, Venatorx Pharmaceuticals
  8. Factors associated with methicillin resistance in Staphylococcus aureus: a case-case-control analysis of AMR surveillance data
    European Journal of Clinical Microbiology & Infectious DiseasesData Challenge
    Data from: Pfizer
  9. Integrating GIS and Genomics for AMR One Health Drug Target Discovery in Imipenem-Resistant Escherichia coli
    Wellcome Open ResearchData Challenge
    Data from: Pfizer
  10. Prioritization of antimicrobial resistance surveillance of gram-negative pathogens: a stacked modelling approach
    Wellcome Open ResearchData Challenge
    Data from: Pfizer
  11. Surveillance-Driven Machine Learning for Prediction of Antimicrobial Susceptibility: An Explainable Modeling Framework using the Pfizer ATLAS Dataset (2004–2023)
    Wellcome Open ResearchData Challenge
    Data from: Pfizer
  12. Temporal links between ambient air pollutants and antifungal resistance dynamics in Candida glabrata: Insights from the Vivli AMR data challenge
    Wellcome Open ResearchData Challenge
    Data from: Pfizer
  13. Ten-Year Evolution of Voriconazole Susceptibility in Aspergillus fumigatus: A Multicenter Analysis of the VIVLI/SENTRY Antifungal Surveillance Platform (2010–2020)
    Preprints.orgPreprint
    Data from: Pfizer
  14. Ten-Year Voriconazole Susceptibility Trends Among 1482 Clinical Aspergillus fumigatus Isolates: A Compositionally Controlled Multicenter Analysis of the VIVLI/SENTRY Platform (2010–2020)
    Journal of Fungi
    Data from: Pfizer
  15. Using GIS Dashboards to highlight AMR data disparities in Africa for Policy, Research, and Public Health
    PLOS One
    Data from: GSK, Johnson & Johnson, Pfizer, Shionogi, Venatorx Pharmaceuticals

2025 11 publications

  1. AMROrbit: Reimagining AMR Stewardship through an Open Source, Dynamic, Actionable Scorecard from Routine Microbiology Data
    medRxivPreprintData Challenge
    Data from: Pfizer
  2. Application of statistical and machine learning methods to predict antimicrobial susceptibility to blood borne microorganisms to support administrative and policy level decision making
    Wellcome Open ResearchData Challenge
    Data from: Pfizer
  3. Country-level heterogeneity in MDR-TB drug susceptibility supports country-specific policy development
    Frontiers in Tuberculosis
    Data from: Johnson & Johnson
  4. Distribution of beta-lactamase genes in Enterobacteriaceae from human clinical samples
    Infectious Diseases NowData Challenge
    Data from: Pfizer
  5. Empowering Global AMR Research Community: Interactive GIS dashboards for AMR data analysis and informed decision-making
    Wellcome Open ResearchData Challenge
    Data from: Pfizer
  6. Epidemiological Distributions of Beta-lactamase Genes in Enterobacteriaceae at One Health Interface in the United States
    Texas Tech UniversityThesisData Challenge
    Data from: Pfizer
  7. Global distribution and incidence of multidrug resistant and ESBL producing Escherichia coli: an observational study of the ATLAS dataset
    Clinical Epidemiology and Global HealthData Challenge
    Data from: Pfizer
  8. Global Prediction of Antimicrobial Resistance Trends Using Statistical and Machine Learning Models: Evaluating National Action Plan Policy Impacts Through Interrupted Time Series Analysis
    Journal of Global Antimicrobial Resistance
    Data from: Pfizer
  9. MicroBIS: An integrated AI laboratory assistant for Bacteria and Antimicrobial Resistance Identification
    Wellcome Open ResearchData Challenge
    Data from: Pfizer
  10. Prediction of antibiotic resistance from antibiotic susceptibility testing results from surveillance data using machine learning
    Scientific ReportsData Challenge
    Data from: Pfizer
  11. Supervised Learning Model Systems to Predict and Identify Drivers of AMR in Africa
    Wellcome Open ResearchData Challenge
    Data from: Pfizer

2024 8 publications

  1. A predictive algorithm for the analysis of AMR trends and healthcare decision support
    Wellcome Open ResearchData Challenge
    Data from: Pfizer
  2. Antibiotic susceptibility trend estimation for India based on 2018 to 2021 data from GEARS program
    medRxivPreprintData Challenge
    Data from: Venatorx Pharmaceuticals
  3. AntiMicro.ai: an artificial intelligence powered web application for predicting antibacterial/antifungal susceptibility and constructing personalized machine learning models
    Wellcome Open ResearchData Challenge
    Data from: Pfizer
  4. bla SED-1 beta-lactamase-producing Citrobacter sedlakii isolated from horses and genomic comparison with human-derived isolates
    Journal of Applied MicrobiologyData Challenge
    Data from: Pfizer
  5. Colistin Sparing Strategies to Overcome Resistance: Can We Save Future!
    SSR Institute of International Journal of Life SciencesData Challenge
    Data from: Pfizer
  6. Investigating the feasibility and potential of combining industry AMR monitoring systems: a comparison with WHO GLASS
    Wellcome Open ResearchData Challenge
    Data from: GSK, Johnson & Johnson, Paratek Pharmaceuticals, Pfizer, Shionogi, Venatorx Pharmaceuticals
  7. MIC distribution analysis identifies differences in AMR between population sub-groups
    Wellcome Open ResearchData Challenge
    Data from: GSK, Paratek Pharmaceuticals, Pfizer, Venatorx Pharmaceuticals
  8. Predictive Modeling of Phenotypic Antimicrobial Susceptibility of Selected Beta-Lactam Antimicrobials from Beta-Lactamase Resistance Genes
    AntibioticsData Challenge
    Data from: Pfizer

Did you publish research using AMR Register data and don’t see it here? Contact us and we will add it.

Last updated November 2026.